StackWave
@stackwave
Simplifying Software for the Life Sciences.
Może Ci się spodobać
StackWave Affinity LIMS for antibody discovery supports your entire process from target identification and campaign initiation through lead identification and characterization. Download our on-demand webinar and demo now: #StackWaveAffinity bit.ly/3HfLu1B
We want to express our gratitude to everyone who attended our presentation at #AET23 this year: Software at Every Stage: Achieving Antibody Discovery at Scale. Your presence made it a tremendous success! 🙌 #StackWave #AntibodyDiscovery #Innovation
#AET23 Scientific Briefing - Software at Every Stage: Achieving Antibody Discovery at Scale 12/14 at 1:45pm PST bit.ly/3GFljBB
Data is essential to developing new medicines, but managing it can be a challenge. Bioregistries support modeling, recording, and querying data at scale to simplify management and make data more FAIR. #biotech #antibodydiscovery #drugdiscovery bit.ly/40ZOGYZ
Phage display enables screening and selection of molecules with desired binding properties. It has revolutionized the discovery of #nanobodies. See how to prepare a phage display library for nanobody discovery. #antibodydiscovery #biotech #drugdiscovery bit.ly/46qM3QV
5 issues during cDNA library preparation for NGS (and solutions): 1. Poor quality RNA 2. Inefficient reverse transcription 3. Low cDNA yield 4. Adapter dimer formation 5. Inconsistent fragment size #ngs #cdna #biotech #antibodydiscovery #drugdiscovery bit.ly/3SKcWMo
NGS has transformed fields like genomics, transcriptomics, and immunology. It enables efficient identification of VHH regions from B-cells. This article explores NGS for antibody identification and VHH extraction. #nanobodies #ngs #drugdiscovery #biotech bit.ly/3FT272Q
Scientists harness #nanobodies to combat viral and bacterial infections, using their small size to access viral and bacterial components larger molecules might not reach, such as the spike protein of SARS-CoV-2. #antibodydiscovery #biotech #drugdiscovery bit.ly/3Spj10x
Scientists explore the potential of #nanobodies for treating neurodegenerative diseases. They are small, stable, specific molecules that show promise in clearing accumulated proteins and preventing cell death. #antibodydiscovery #biotech #drugdiscovery bit.ly/3tUYO8Z
#Nanobodies: Promising weapons in the fight against cancer. These small, stable, highly-specific antibody fragments show enormous potential in targeted therapy through various mechanisms of action. #antibodydiscovery #biotech #drugdiscovery bit.ly/3QDyvgo
#Nanobodies: small, stable antibody fragments derived from camelids. High potential in diagnostics, imaging, and therapeutics. Unique properties: small size, high stability, specificity, low immunogenicity. #antibodydiscovery #biotech #drugdiscovery bit.ly/470WMSL
#ngs technology has revolutionized #antibodydiscovery. Bulk B cell sequencing enables analysis of the antibody repertoire and identification of therapeutic antibodies. This blog post explores bulk B cell analysis via NGS and its role in antibody discovery. bit.ly/3Fs2EbU
Read about the current state of knowledge of FcRn–IgG immunobiology, with an emphasis on the functional and pathological aspects, and an overview of FcRn-targeted therapy development. #AntibodyResearch #Biotech go.nature.com/40McRcB
Part 3 of the DrugOps blog series talks about the power of using software to orchestrate the steps in drug discovery workflows #AntibodyDiscovery bit.ly/40YDgEs
Moderna acquires a synthetic biology specialist, OriCiro, which launched in December 2018. Its technology offers “a highly strategic fit with @moderna_tx” #Biotech bit.ly/40M7A4T
Bristol Myers CMO, others still skeptical about cancer vaccines as @BioNTech_Group, @moderna_tx march ahead with I-O partners bit.ly/3x7tYYZ #Therapeutics #Pharma
fiercebiotech.com
Bristol Myers CMO, others still skeptical about cancer vaccines as BioNTech, Moderna march ahead...
Moderna and BioNTech recently reported positive early clinical data for their mRNA cancer vaccines in partnership with PD-1/L1 inhibitors. | Moderna and BioNTech recently reported positive early...
Purple Biotech to paint with Immunorizon's tri-specific antibodies in small M&A deal bit.ly/40Gt3ft #AntibodyResearch #AntibodyDiscovery
Singapore’s drug discovery efforts reached a new milestone as EBC-129, the first made-in- Singapore antibody-drug conjugate, was cleared by the US FDA to progress into first-in-human studies. #AntibodyDiscovery
Researchers have generated more preclinical evidence that intranasal delivery can get antibodies to the brain, presenting data that suggest the administration route can achieve concentrations close to those provided by invasive intrathecal infusions. bit.ly/3l0y2Yc
Another issue is data ‘leakage’: overlap between the data used to train a model and the data used to test it. But medical databases can include entries for the same patient, duplications that scientists who use the data might not be aware of. go.nature.com/3j3rgjX
United States Trendy
- 1. Good Sunday N/A
- 2. Muhammad Qasim N/A
- 3. Jesus is the Son of God N/A
- 4. Alex Pretti N/A
- 5. #tiktokdown N/A
- 6. #sundaymotivation N/A
- 7. #SundayFunday N/A
- 8. Paddy N/A
- 9. Kyle Rittenhouse N/A
- 10. #SundayMorning N/A
- 11. Laken Riley N/A
- 12. #tspotter N/A
- 13. Championship Sunday N/A
- 14. LINGORM HONGKONG MEET N/A
- 15. PERTHSANTA BABYMATTE CUSHION N/A
- 16. Learner Tien N/A
- 17. Noem N/A
- 18. Tracy N/A
- 19. Gaethje N/A
- 20. Cutch N/A
Może Ci się spodobać
Something went wrong.
Something went wrong.